DrugIn clinical trials
Pelacarsen
pelacarsen
Novartis/Ionis; Lp(a)HORIZON Phase 3 — исход 04.09.2026 сообщён как miss.
No news refers to this card yet.
Scales
Identifiers
- INN
- pelacarsen
Details
- Status
- In clinical trials
- Class
- антисмысловой препарат (снижение продукции apo(a) и Lp(a))
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.